|Bid||6.88 x 900|
|Ask||6.89 x 1100|
|Day's range||6.64 - 6.98|
|52-week range||4.77 - 31.80|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2021 - 12 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.86|
The Ford F-150 Lightning electric pickup hasn't even gone on sale yet, but demand is so red hot that the automaker is already ramping up production.
The SPAC market continues to be touch and go, and well off the euphoria seen late in 2020.
Although a vast majority of Wall Street ratings and price targets on publicly traded companies portend upside, some analysts see nothing short of calamity in the months and years that lie ahead for some of the most popular stocks. Based on the lowest Wall Street price target, the following three ultra-popular stocks could tumble between 81% and 98%. Biotech stock Moderna (NASDAQ: MRNA) has been one of the fastest-growing and most successful investments since the beginning of 2020.